Women As One ads

Is your CV passing the recruiter filter? Upload your resume to our CV Analyzer for an instant score and keyword optimization. Your CV should be a powerful testament to your impact, leadership, and expertise, not just a list of past roles. Women As One’s AI-powered CV Analyzer is custom-built for women in cardiology to elevate your achievements, optimize your profile, and position you for your next major career breakthrough. Receive personalized, actionable feedback, including: • A review and rating of your CV • Recommendations to strengthen how you present your achievements • Headline and biography suggestions • Practical CV tips and improvements • Suggestions for your next career steps Upload your CV in any language, with your personalized report currently delivered in English. Ready to unlock your full potential and command the recognition you deserve? Join The Pulse to access the CV Analyzer and accelerate your cardiology career. Sign up today: https://lnkd.in/dDYqjEmu/?utm_campaign=CVanalyzerpost1boost5th-19th&utm_source=linkedin&utm_medium=paid&utm_id=1248659554&hsa_acc=510765224&hsa_cam=1248659554&hsa_grp=906766524&hsa_ad=1631458384&hsa_net=linkedin&hsa_ver=3 #WomenInCardiology #WomenInMedicine #Medicine #Cardiology

Pregnancy can offer important insights into a woman’s cardiovascular health, with implications that extend far beyond delivery. Authors highlight persistent gaps in the evidence guiding the prevention, diagnosis, and management of maternal cardiovascular disease. Addressing these gaps is essential to improving care during pregnancy and supporting women’s long-term cardiovascular health. Key priorities include: • Building more inclusive research - studies must better reflect the diversity of women affected by cardiovascular disease. • Strengthening patient partnership - women with lived experience should help shape research priorities, study design, and outcomes that matter to patients and families. • Improving long-term follow-up - pregnancy and postpartum care offer opportunities to identify cardiovascular risks and support prevention across a woman’s life course. Closing the evidence gap requires coordinated research, collaboration across specialties, and meaningful patient involvement. Women As One is committed to advancing women’s leadership and equity in cardiovascular care, helping ensure that women’s experiences and health needs are represented in the evidence that informs clinical practice. Article: https://lnkd.in/g8ZrQESH #WomensHealth #CardiovascularDisease #Cardiology #HealthEquity Paz Tayal, Antonio de Marvao, JAMA Cardiology

How can we move cardiovascular medicine forward? By bringing world-leading experts together to share knowledge, challenge perspectives, and shape the conversations that matter. At RISE @ ESC Congress 2026, Women As One brought together leaders in cardiology to exchange ideas, share perspectives, and explore actionable ways to make progress. In this video, attendee reflections highlight the value of learning from leading experts, exchanging ideas with global colleagues, and creating space for women to contribute to important conversations in cardiovascular medicine. Watch the video, then join the community: https://lnkd.in/gM29a5ef #LetsRISE26 #ESCCongress #WomenInCardiology #WomenAsOne European Society of Cardiology Pamela Douglas, Maria Rubini, Zainab Samad, Malissa Wood, Borjana Pervan, Josephine Achan, Jennifer H. Mieres, MD , FACC, MASNC, FAHA, Shrilla Banerjee, Natalia Cotic, Chahinda Ghossein

Cardiovascular health needs to be considered across every stage of a woman’s life. The American Heart Association’s Cardiovascular Health in Girls and Women Compendium brings together guidance to help clinicians better recognize and address cardiovascular risks specific to girls and women. Key takeaways include: - Consider the full life course: Cardiovascular risk and care needs evolve from puberty and reproductive years through perimenopause and postmenopause. - Connect the dots: Hormonal, psychosocial, and cardiovascular health are interconnected and should be considered together in clinical practice. - Translate evidence into action: Life stage-specific guidance can support tailored screening, prevention, diagnosis and treatment. - Build collaborative care: Interdisciplinary care models, workforce education and research can help improve outcomes and reduce inequities. Advancing cardiovascular health requires recognizing a woman's needs throughout her life and ensuring that women physicians have the leadership opportunities to shape more equitable, evidence-informed care. Explore the compendium and its clinical resources: https://lnkd.in/ewfB6t8s #WomensHeartHealth #CardiovascularHealth #WomenInMedicine #HealthEquity American Academy of Pediatrics, American College of Obstetricians and Gynecologists (ACOG), The Society for Maternal-Fetal Medicine, Nancy Brown

Women represent approximately half of the atrial fibrillation (AF) population, yet they remain underrepresented in AF clinical studies. A recent research letter examines sex-specific outcomes after catheter ablation in patients with AF and left ventricular systolic dysfunction. The study pooled data from three randomized clinical trials to explore whether sex was associated with clinical response to catheter ablation in this higher-risk population. The outcomes tell an important story: 🔹AF recurrence was similar - 45% in women vs. 43% in men. 🔹Both women and men experienced substantial improvement in left ventricular ejection fraction, with a 20% improvement at 12 months. 🔹Both groups demonstrated left atrial reverse remodeling and very low AF burden after ablation. 🔹Heart failure hospitalization and healthcare utilization were low, with no significant differences by sex. 🔹Women and men reported comparable improvements in symptoms and quality of life. The study concluded that women with AF and LVSD achieved improvements in cardiac function, atrial remodeling, rhythm control, and heart failure outcomes equivalent to men. This challenges assumptions that women may experience poorer outcomes after catheter ablation and reinforces that women should have equitable access to rhythm-control strategies when clinically appropriate. However, women represented just 20% of the study population. Increasing women's representation is vital to ensure we're generating evidence that can help clinicians make informed decisions for women with cardiovascular disease. 📖 Article: https://lnkd.in/gtHZmVYy #WomenInCardiology #WomensCardiovascularHealth #WomenAsOne Louise Segan, Kenneth Cho, David Chieng, Jeremy William, Nicholas D'Elia, Han Ling, Professor Richard Schilling, Manish Kalla, Peter Kistler, JAMA Cardiology

A recent study examines how lipoprotein(a), or Lp(a), changes across the menopausal transition and raises important questions about when we measure this inherited cardiovascular risk factor. Among 4,562 women from the UK Biobank, researchers found: 🔹 Overall, changes in Lp(a) were modest, but the pattern was different for women transitioning through menopause. 🔹 Among women with intermediate Lp(a) levels (75–125 nmol/L) at the first visit, those who transitioned through menopause experienced a median increase of 34.9 nmol/L, approximately four times the increase seen among women who remained premenopausal or postmenopausal. 🔹 More than half (56%) of women with intermediate Lp(a) who transitioned through menopause crossed the risk-enhancing threshold at follow-up, compared with 29% of women who remained premenopausal and 28% of women who remained postmenopausal. 🔹 The findings suggest that a single lifetime Lp(a) measurement may not capture changes in cardiovascular risk during menopause. While the findings do not establish that menopause itself causes the observed Lp(a) changes, they raise the question of evolving cardiovascular risk assessment for women as they move through menopause. We believe women’s cardiovascular health requires a life-course perspective that recognizes important biological transitions and ensures that evidence and prevention strategies reflect them. 📖 Article: https://lnkd.in/gWJcWw4K #WomenAsOne #WomensCardiovascularHealth #WomensHealth #Menopause Christy Avery, Christie Ballantyne MD, Anne Marie Jukic, Annie Green Howard, European Association of Preventive Cardiology - EAPC, European Society of Cardiology